
|Articles|July 1, 2012
- Pharmaceutical Executive-07-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - July 2012
2012 Emerging Pharma Leaders
Advertisement
Articles in this issue
about 14 years ago
Emerging Pharma Leaders 2012about 14 years ago
Who Will Pay for New Drugs?about 14 years ago
Less, But Betterabout 14 years ago
John Lechleiter on PhRMA and Innovationabout 14 years ago
Today's Mission Critical: Making Sense of Spending on Clinical Trialsabout 14 years ago
The Learning Curveabout 14 years ago
Marketing: Why the Conversation Has Changed — ForeverAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Pannel Votes to Loosen Restrictions for Four Peptides
2
Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides
3
President Trump Announces Phased Generic Drug Tariff Plan: Report
4
Retatrutide Delivers Up to 22.6% Weight Loss in Two New Phase III Trials
5




